India's Pharmaceutical Exports Approach $29 Billion Amid Global Challenges

Original: India’s pharma exports stay resilient amid global headwinds, near $29 billion mark

The Economic Times•Apr 4, 20262 min

In a Nutshell

India's pharmaceutical exports are nearing $29 billion for the financial year, showing a 5.6% growth compared to the previous year. Despite global market volatility, the sector remains resilient, driven by high-value products like formulations and vaccines, with expectations to double in size by 2030.

Key Points

01Pharmaceutical exports reached $28.29 billion from April to February FY26.
02The sector registered a growth of 5.6% compared to the same period in FY25.
03India's pharmaceutical industry is valued at around $60 billion and is projected to reach $130 billion by 2030.
04High-value segments such as formulations and vaccines are key drivers of growth.
05Export performance remains strong despite global pricing pressures and trade uncertainties.

In-Article Ad

Full Summary

India's pharmaceutical exports are poised to reach nearly $29 billion by the end of the financial year, with a reported 5.6% growth from the previous year. K Raja Bhanu, Director General of the Pharmaceuticals Export Promotion Council of India (PHARMEXCIL), highlighted that despite global market volatility, the sector has shown resilience. Exports during the April-February FY26 period amounted to $28.29 billion, primarily driven by high-value segments such as formulations, biologicals, vaccines, and Ayush products. The pharmaceutical industry, currently valued at $60 billion, is expected to more than double to $130 billion by 2030, indicating strong long-term growth prospects. The robust export performance is noteworthy given the pricing pressures and trade uncertainties faced globally, with shipments increasing to $30.47 billion in FY 2024-25, a 9.4% year-on-year increase.

Key Figures

$28.29 billion

Pharmaceutical exports from April to February FY26

5.6%

Growth compared to the same period in FY25

$60 billion

Current valuation of India's pharmaceutical industry

$130 billion

Projected valuation of the industry by 2030

In-Article Ad

Why It Matters

The growth in pharmaceutical exports indicates a strong demand for Indian medicines globally, which could lead to increased employment and investment in the sector.

Who is affected

pharmaceutical manufacturers, healthcare providers, and consumers of medicines

What to know

Pharmaceutical companies should continue to innovate and expand their product offerings to meet global demand.

FAQ

India's pharmaceutical industry is currently valued at around $60 billion.

The growth is primarily driven by high-value segments such as formulations, biologicals, vaccines, and Ayush products.

✦